Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 3422 Records) |
Query Trace: Neoplasms and KRAS[original query] |
---|
Genomic ancestry and cancer among Latin Americans. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 4 . Alejandro Ruíz-Patiño, Leonardo Rojas, Jairo Zuluaga, Oscar Arrieta, Luis Corrales, Claudio Martín, Sandra Franco, Luis Raez, Christian Rolfo, Natalia Sánchez, Andrés Felipe Cardo |
Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I-III colorectal cancer. Medicine 2024 4 103 (14): e37693. Weicheng Wang, Rui Wang, Xiao Han, Wei Zhang, Lijun Zhu, Yanhong |
Lung Cancer Clinical Trials in Latin America in the Era of Cooperative Groups: A 20-Year Analysis. JCO global oncology 2024 4 10 e2300379. Thomas Knapp, Joseph Nygaard, Joshua Cassinat, Fernando Galvez, Priya K Gopal |
Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model. Microbiology spectrum 2024 4 e0272023. Zigui Huang, Xiaoliang Huang, Yili Huang, Kunmei Liang, Lei Chen, Chuzhuo Zhong, Yingxin Chen, Chuanbin Chen, Zhen Wang, Fuhai He, Mingjian Qin, Chenyan Long, Binzhe Tang, Yongqi Huang, Yongzhi Wu, Xianwei Mo, Tang Weizhong, Jungang L |
Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients. Heliyon 2024 4 10 (7): e29299. Bo Cheng, Lin Xu, Yunzhi Zhang, Huimin Yang, Shan Liu, Shanshan Ding, Huan Zhao, Yi Sui, Chan Wang, Lanju Quan, Jinhong Liu, Ye Liu, Hongming Wang, Zhaoqing Zheng, Xizhao Wu, Jing Guo, Zhaohong Wen, Ruya Zhang, Fei Wang, Hongmei Liu, Suozhu S |
Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 4 . Ke Wang, Manyi Xu, Yanhua Wang, Chunwei Xu, Yue Hao, Zhengbo So |
Clinical utility of circulating tumor DNA in patients with advanced KRAS-mutated non-small cell lung cancer treated with sotorasib. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 4 . Sophie M Ernst, Ronald van Marion, Peggy N Atmodimedjo, Evert de Jonge, Ron H J Mathijssen, Marthe S Paats, Peter de Bruijn, Stijn L Koolen, Jan H von der Thüsen, Joachim G J V Aerts, Ron H N van Schaik, Hendrikus J Dubbink, Anne-Marie C Dingema |
The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic Profiling. Targeted oncology 2024 4 . Hiroyuki Yamamoto, Hiroyuki Arai, Ritsuko Oikawa, Kumiko Umemoto, Hiroyuki Takeda, Takuro Mizukami, Yohei Kubota, Ayako Doi, Yoshiki Horie, Takashi Ogura, Naoki Izawa, Jay A Moore, Ethan S Sokol, Yu Sunaka |
Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort. Cancers 2024 4 16 (7): . Rossella Bruno, Anello Marcello Poma, Martina Panozzi, Alessandra Lenzini, Gianmarco Elia, Carmelina Cristina Zirafa, Vittorio Aprile, Marcello Carlo Ambrogi, Editta Baldini, Marco Lucchi, Franca Melfi, Antonio Chella, Andrea Sbrana, Greta A |
SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel. Cancers 2024 4 16 (7): . Kohei Yamashita, Matheus Sewastjanow-Silva, Katsuhiro Yoshimura, Jane E Rogers, Ernesto Rosa Vicentini, Melissa Pool Pizzi, Yibo Fan, Gengyi Zou, Jenny J Li, Mariela Blum Murphy, Qiong Gan, Rebecca E Waters, Linghua Wang, Jaffer A Aja |
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation. Clinical lung cancer 2024 1 . Adam Barsouk, Cole Friedes, Michelle Iocolano, Abigail Doucette, Roger B Cohen, Kyle W Robinson, Christopher A D'Avella, Melina E Marmarelis, John A Kosteva, Aditi P Singh, Christine A Ciunci, William P Levin, Keith A Cengel, Jeffrey D Bradley, Steven J Feigenberg, Lova Sun, Charu Aggarwal, Corey J Langer, Nikhil Yegya-Ram |
Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2024 1 191 110082. Xingping Zhang, Guijuan Zhang, Xingting Qiu, Jiao Yin, Wenjun Tan, Xiaoxia Yin, Hong Yang, Hua Wang, Yanchun Zha |
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist? British journal of cancer 2024 1 . Débora Contreras-Toledo, Paula Jiménez-Fonseca, Carlos López López, Ana Fernández Montes, Ana María López Muñoz, Francisca Vázquez Rivera, Vicente Alonso, Julia Alcaide, Francesc Salvà, Marta Covela Rúa, Mónica Guillot, Alfonso Martín Carnicero, Raquel Jimeno Mate, Soledad Cameselle García, Elena Asensio Martínez, Beatriz González Astorga, Amaya B Fernandez-Diaz, Paula González Villaroel, Anna C Virgili Manrique, Marcos Melián Sosa, Beatriz Alonso, Antia Cousillas Castiñeiras, Carmen Castañón López, Jorge Aparicio, Alberto Carmona-Bayon |
Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies. Gene 2024 1 899 148134. Yajing Chi, Hongtu Yuan, Qing Fan, Zhendan Wang, Zuoxing Niu, Jinming Yu, Dandan Yu |
Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer. Therapeutic advances in medical oncology 2024 1 16 17588359231225035. Xiang Zhang, Haizhong Ma, Yinjun He, Wenguang He, Nan Chen, Yandong Li, Weixiang Zhong, Guosheng Wu, Xile Zhou, Hanju Hua, Feng Ye, Hui Cai, Weiqin Jia |
Genetic and immunologic characteristics of colorectal cancer patients with KRAS mutations and predictive significance of tumor immune microenvironment in adjuvant chemotherapy. Genes & diseases 2024 1 11 (3): 100983. Zhengqi Wen, Wenliang Li, Chengmin Shi, Junrui Ma, Sihui Zhao, Ruize Zhou, Xihong Liu, Rong Yang, Zhiping Zhang, Hushan Zhang, Bo |
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo. Nature communications 2024 1 15 (1): 100. Arafath K Najumudeen, Sigrid K Fey, Laura M Millett, Catriona A Ford, Kathryn Gilroy, Nuray Gunduz, Rachel A Ridgway, Eve Anderson, Douglas Strathdee, William Clark, Colin Nixon, Jennifer P Morton, Andrew D Campbell, Owen J Sans |
[Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lung and its associated lung cancer in adults]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 1 53 (2): 130-135. L Liang, C Y Wu, L P Zhang, L K Hou, Z W Dong, W Wu, Y Huang, H K X |
Association of Orai1 and Peizo1 genes expression with cellular proliferation, metastasis and angiogenesis biomarkers in colon tumor biopsies of CRC patients. Cellular and molecular biology (Noisy-le-Grand, France) 2024 1 69 (14): 232-236. Farhang Awla, Goran Othm |
Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer. Journal of cancer research and clinical oncology 2024 1 150 (2): 35. Hideki Motobayashi, Yuji Kitahata, Ken-Ichi Okada, Motoki Miyazawa, Masaki Ueno, Shinya Hayami, Atsushi Miyamoto, Atsushi Shimizu, Masatoshi Sato, Tomohiro Yoshimura, Yuki Nakamura, Norio Takemoto, Tomoki Nakai, Takahiko Hyo, Kyohei Matsumoto, Hiroki Yamaue, Manabu Kaw |
RAS Mutations Predict Recurrence-Free Survival and Recurrence Patterns in Colon Cancer: A Unicenter Study in Morocco. Cancer control : journal of the Moffitt Cancer Center 2024 1 31 10732748241229290. Fatima El Agy, Sanae El Bardai, Sara Boukansa, Laila Bouguenouch, Zineb Benbrahim, Khalid Mazaz, El Bachir Benjelloun, Abdelmalek Ousadden, Karim Ouldim, Sidi Adil Ibrahimi, Laila Chba |
Higher Inflammatory Response in Hepatocellular Carcinoma is Associated with Immune Cell Infiltration and a Better Outcome. Research square 2024 1 . Masanori Oshi, Kohei Chida, Arya Mariam Roy, Gabriella Kim Mann, Nan An, Li Yan, Itaru Endo, Kazuaki Taka |
Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer. Cancer biomarkers : section A of Disease markers 2024 1 . Ahmed Saeed Abd ELhafeez, Hala Mostafa Ghanem, Menha Swellam, AlShaimaa Mohamed Ta |
Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. Current oncology (Toronto, Ont.) 2024 1 31 (1): 274-295. Juan Pablo Cayún, Leslie Carol Cerpa, Alicia Colombo, Dante Daniel Cáceres, José Luis Leal, Felipe Reyes, Carolina Gutiérrez-Cáceres, Susan Calfunao, Nelson Miguel Varela, Luis Abel Quiñon |
KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges. Pathology oncology research : POR 2024 1 29 1611580. Judit Moldvay, József Tím |
Clinicopathological and molecular characteristics of colorectal adenosquamous carcinoma in an Asian population. BMC gastroenterology 2024 1 24 (1): 36. Fujin Ye, Mian Chen, Xiaobin Zheng, Pinzhu Huang, Chao Wang, Huashan Liu, Hao Xie, Wei Xiao, Qin Guo, Liang Hua |
DNA Marker in Stool Led to a Second High-Quality Colonoscopy Within Three Months and Removal of an Undetected High-Risk Polyp. Clinical laboratory 2024 1 70 (1): . Susanne Franck, Moritz Eidens, Jürgen Fuhrländer, Dagfinn Ogre |
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy. International journal of molecular sciences 2024 1 25 (1): . Karen Gambaro, Maud Marques, Suzan McNamara, Mathilde Couetoux du Tertre, Cyrla Hoffert, Archana Srivastava, Anna Schab, Thierry Alcindor, Adrian Langleben, Lucas Sideris, Mahmoud Abdelsalam, Mustapha Tehfe, Felix Couture, Gerald Batist, Petr Kav |
Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics. Cancers 2024 1 16 (1): . Qian Xi, Hidenori Kage, Miho Ogawa, Asami Matsunaga, Akira Nishijima, Kenbun Sone, Kei Kawana, Katsutoshi O |
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma". Thoracic cancer 2024 1 . Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, Tetsuya Isaka, Kanako Shinada, Emi Yoshioka, Atsuya Narita, Kengo Katakura, Tetsuro Kondo, Terufumi Kato, Takuya Nagashima, Haruhiro Saito, Hiroyuki I |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: